Anti-Asthma TDM Assay Kits Market Size & Share, by Product Type (ELISA Assay Kits, Immunoassay Kits); Assay Type (Anti-Asthma, Bronchodilator); End-user (Hospitals, Diagnostic Laboratories, Research Centers & Academic Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4143
  • Published Date: Feb 20, 2023
  • Report Format: PDF, PPT

Companies Dominating the Anti-Asthma TDM Assay Kits Landscape

    • F. Hoffmann-La Roche Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Bio-Techne Corporation
    • Svar Life Science AB
    • Thermo Fisher Scientific Inc.
    • Eagle Biosciences, Inc.
    • Merck KGaA
    • Elabscience Biotechnology Inc.
    • MyBioSource Inc.
    • Creative Diagnostics
    • Diagnostic Automation (Cortez Diagnostics, Inc.)

Browse Key Market Insights with Data Illustration:


In The News

  • Thermo Fisher Scientific joins hands with TransMIT GmbH on an Orbitrap Mass Spectrometry Imaging Platform.

  • Carterra and Bio-Techne, a leading supplier of innovative and high-quality tools for life science research, collaborated on clinical research for the COVID-19 variant analysis.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4143
  • Published Date: Feb 20, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The rising cases of asthma, rising air pollution, and growing demand for anti-asthma drugs are expected to be the major factor driving the growth of the global anti-asthma TDM assay kits market during the forecast period.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2035.

Lack of awareness regarding anti-asthma TDM assay kits, and there are very less skilled workers present to perform this test are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Bio-Techne Corporation, Svar Life Science AB, Thermo Fisher Scientific Inc., Eagle Biosciences, Inc., Merck KGaA, Elabscience Biotechnology Inc., MyBioSource Inc., Creative Diagnostics, Diagnostic Automation (Cortez Diagnostics, Inc.), and F. Hoffmann-La Roche Ltd.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product type, assay type, end user, and by region.

The ELISA assay kits segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying